Walden Group Arranges the Sale of Millennium Surgical to Avalign Technologies

The Walden Group is pleased to announce that it represented Millennium Surgical Corp. in its sale to Avalign Technologies, Inc.

Pioneering a new approach, Millennium is an innovative supplier of surgical instruments to OEMs, distributors, hospitals and surgery centers. Utilizing sophisticated web-based marketing tools, electronic cataloging and cross-referencing of virtually all instrument brands, the company has become the "go to" source for "hard to find" specialty products. With systems that enable surgical suite personnel to compare products and features, deep instrument knowledge and prompt and reliable customer service, Millennium has built a loyal and growing customer base.
Avalign is a full-service supplier of surgical implants, instruments, and delivery systems and a portfolio company of Arlington Capital.

Representing Millennium, The Walden Group positioned the company to take advantage of its unique business model, conducted a discerning process, advised the principals, facilitated negotiations, and guided the transaction to a successful closing.

About The Walden Group

The Walden Group is a healthcare investment banking and consulting firm combining merger & acquisition and strategic consulting services. Its approach is close-to-operations in lockstep with business development and C-Suite executives of medical device, diagnostic, healthcare IT, service and other companies within the sector. It represents companies seeking to divest operations and find a "home" within a larger company or private equity firm that can better commercialize its product lines. It also represents larger operating companies and financial sponsors seeking to grow by corporate acquisition. It is expert in identifying and building rapport with strategically fitted candidates and guiding transactions to completion. See www.waldenmed.com.

The Walden Group, Inc.
560 White Plains Rd.
Tarrytown, NY 10591
914.332.9700
www.waldenmed.com

Keywords: healthcare investment banking, healthcare M&A, healthcare mergers